ARCHIVES

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

NCI Formaldehyde Finding Criticized

March 7, 1986

CIS Celebrates 15th Anniversary, Praised By M. Quayle

December 6, 1991

National Toxicology Program: Saccharin No Longer Listed as Carcinogen in NTP Report

May 19, 2000

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

New Atlas Showing nonwhite Mortality Rates Available

January 7, 1977